Binding Affinity Determination in Drug Design: Insights from Lock and Key, Induced Fit, Conformational Selection, and Inhibitor Trapping Models
International Journal of Molecular Sciences · 28.06.2024 · 25 (13) · 7124
DOI: 10.3390/ijms25137124 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.06.2024. Verfasst von Danislav S Spassov. Beteiligte Einrichtung: Drug Design and Bioinformatics Lab, Department of Chemistry, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria. Hauptthemen laut MEDLINE: Drug Design, Protein Binding, Proteins. Die Arbeit wurde bisher 100-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria,, Centre of Excellence for Informatics and ICT, supported by the Science and Education for Smart Growth Operational Program and co-financed by the European Union…, Centre of Excellence for Informatics and ICT.
Abstract (Originalsprache)
Binding affinity is a fundamental parameter in drug design, describing the strength of the interaction between a molecule and its target protein. Accurately predicting binding affinity is crucial for the rapid development of novel therapeutics, the prioritization of promising candidates, and the optimization of their properties through rational design strategies. Binding affinity is determined by the mechanism of recognition between proteins and ligands. Various models, including the lock and key, induced fit, and conformational selection, have been proposed to explain this recognition process. However, current computational strategies to predict binding affinity, which are based on these models, have yet to produce satisfactory results. This article explores the connection between binding affinity and these protein-ligand interaction models, highlighting that they offer an incomplete picture of the mechanism governing binding affinity. Specifically, current models primarily center on the binding of the ligand and do not address its dissociation. In this context, the concept of ligand trapping is introduced, which models the mechanisms of dissociation. When combined with the current models, this concept can provide a unified theoretical framework that may allow for the accurate determination of the ligands’ binding affinity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Drug Design and Bioinformatics Lab, Department of Chemistry, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.
ORCID-Profile: Danislav S Spassov
Förderung
- European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria,
- Centre of Excellence for Informatics and ICT, supported by the Science and Education for Smart Growth Operational Program and co-financed by the European Union…
- Centre of Excellence for Informatics and ICT
Zitieren
APA
Spassov, D. S. (2024). Binding Affinity Determination in Drug Design: Insights from Lock and Key, Induced Fit, Conformational Selection, and Inhibitor Trapping Models. International Journal of Molecular Sciences, 25(13), 7124. https://doi.org/10.3390/ijms25137124
Vancouver
Spassov DS. Binding Affinity Determination in Drug Design: Insights from Lock and Key, Induced Fit, Conformational Selection, and Inhibitor Trapping Models. International Journal of Molecular Sciences. 2024;25(13):7124. doi:10.3390/ijms25137124
BibTeX
@article{Spassov2024,
author = {Spassov, Danislav S},
title = {Binding Affinity Determination in Drug Design: Insights from Lock and Key, Induced Fit, Conformational Selection, and Inhibitor Trapping Models},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {13},
pages = {7124},
doi = {10.3390/ijms25137124}
}
EUVIMED